Diagnostic Performance of PIVKA-II in Identifying Recurrent Hepatocellular Carcinoma following Curative Resection: A Retrospective Cohort Study

A multicenter, retrospective, and observational study was conducted. During the overall follow-up of five years, HCC patients who had curative resection were monitored every three months in the first year post-surgery and every six months thereafter if no recurrence occurred.